Table 2. Correlation between clinicopathologic variables and IL-10 mRNA expression in HCC.
Variable | Cases (120) | –∆∆CtIL-10 ≤0 (N=51) | –∆∆CtIL-10 >0 (N=69) | P* |
---|---|---|---|---|
Gender | 0.140 | |||
Male | 96 | 44 | 52 | |
Female | 24 | 7 | 17 | |
Age (y) | 0.243 | |||
≥50 | 85 | 39 | 46 | |
<50 | 35 | 12 | 23 | |
HBV history | 0.407 | |||
Yes | 92 | 41 | 51 | |
No | 28 | 10 | 18 | |
Differentiation | 0.327 | |||
G1 | 48 | 23 | 25 | |
G2-3 | 72 | 28 | 44 | |
Cirrhosis | 0.193 | |||
Yes | 82 | 37 | 45 | |
No | 38 | 22 | 16 | |
Tobacco | 0.156 | |||
Yes | 76 | 36 | 40 | |
No | 44 | 15 | 29 | |
Alcohol | 0.659 | |||
Yes | 71 | 29 | 42 | |
No | 49 | 22 | 27 | |
Lymph node status | 0.405 | |||
N0 | 42 | 20 | 22 | |
N1 | 78 | 31 | 47 | |
Metastasis classification | 0.002 | |||
M0 | 53 | 31 | 22 | |
M1 | 67 | 20 | 47 | |
AFP (µg/L) | 0.002 | |||
≥30 | 82 | 27 | 55 | |
<30 | 38 | 24 | 14 |
*, statistical significance determined by Pearson’s chi-squared test. IL-10, interleukin-10; HCC, hepatocellular carcinoma; MI, methylation index; HBV, hepatitis B virus; AFP, α-fetoprotein.